Y-27632 dihydrochloride: Selective ROCK1/2 Inhibition for Cell and Cancer Research

Executive Summary: Y-27632 dihydrochloride is a small-molecule inhibitor that targets Rho-associated protein kinases ROCK1 and ROCK2 with high selectivity (IC₅₀ ~140 nM for ROCK1) [ApexBio]. It disrupts Rho-mediated formation of stress fibers and modulates cell cycle progression and cytokinesis [BVT948]. The compound is highly soluble in DMSO (≥111.2 mg/mL) and stable for several months when stored below -20°C [ApexBio]. Y-27632 enhances stem cell viability and suppresses tumor invasion in mouse models [America Peptides]. It is a foundational tool for reproducible studies in cell biology, stem cell research, and cancer biology [L3400].

Biological Rationale

Rho-associated protein kinases (ROCK1 and ROCK2) are serine/threonine kinases that regulate actin cytoskeleton organization, cell shape, motility, and division. Aberrant ROCK signaling is implicated in pathological conditions such as cancer metastasis, fibrosis, and neurodegenerative disease [America Peptides]. Selective inhibition of ROCK1/2 allows dissection of Rho/ROCK pathway contributions to cell proliferation, apoptosis, and migration. Y-27632 dihydrochloride was developed to provide a potent, cell-permeable tool for these studies, with over 200-fold selectivity against related kinases including PKC, MLCK, and PAK [ApexBio]. This specificity minimizes off-target effects, enabling more precise mechanistic analysis compared to less selective inhibitors.

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 binds the catalytic domains of ROCK1 and ROCK2, competitively inhibiting ATP binding and kinase activity. This inhibition blocks phosphorylation of downstream targets such as myosin light chain (MLC) and LIM kinase. The result is reduced actin-myosin contractility, dissolution of stress fibers, and inhibition of focal adhesion formation. In proliferating cells, Y-27632 modulates G1/S cell cycle transition and interferes with cytokinesis, leading to altered cell division dynamics [BVT948]. The compound's selectivity profile (IC₅₀ = 140 nM for ROCK1, K_i = 300 nM for ROCK2, >200-fold selective over PKC) is key for dissecting ROCK-specific effects [ApexBio].

Evidence & Benchmarks

• Y-27632 dihydrochloride inhibits ROCK1 kinase activity with an IC₅₀ of ~140 nM in vitro (ApexBio product page).
• Exhibits over 200-fold selectivity for ROCK1/2 versus other kinases, including PKC, cAMP-dependent protein kinase, MLCK, and PAK (ApexBio product page).
• Reduces prostatic smooth muscle cell proliferation in a dose-dependent manner in vitro (ApexBio product page).
• Enhances stem cell survival during dissociation and passaging, increasing colony formation efficiency (Watanabe et al., Stem Cells 2007 DOI).
• Suppresses tumor invasion and metastasis in mouse models of cancer (Nakajima et al., Cancer Sci 2003 DOI).
• Soluble at ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, and ≥52.9 mg/mL in water; solubility enhanced by warming to 37°C or sonication (ApexBio product page).
• Stock solutions are stable below -20°C for several months; long-term storage of solutions not recommended (ApexBio product page).

This article extends the mechanistic overview in [BVT948] by providing granular use parameters and practical solubility data, and updates the translational insights highlighted in [America Peptides] with the latest benchmarks in cell viability and tumor models.

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is widely employed in:

• Enhancing survival and proliferation of human embryonic stem cells and induced pluripotent stem cells (iPSCs) during subculture [Watanabe 2007].
• Dissecting the role of Rho/ROCK signaling in cytoskeletal reorganization and cell migration [BVT948].
• Inhibiting tumor cell invasion and metastasis in preclinical cancer models [Nakajima 2003].
• Supporting epithelial morphogenesis studies by modulating cell-cell and cell-matrix interactions [L3400].

For a focused analysis of Y-27632 in neurodevelopmental disease models and stem cell viability, see this review, which this article complements by adding solubility and workflow data.

Common Pitfalls or Misconceptions

• Y-27632 does not inhibit kinases outside the ROCK family at relevant concentrations; observed effects on non-ROCK pathways usually reflect off-target toxicity or excessive dosing.
• Long-term storage of Y-27632 solutions, even at -20°C, may result in decreased potency; always prepare fresh aliquots for critical experiments.
• ROCK inhibition by Y-27632 is reversible; removal from culture media rapidly restores stress fiber formation.
• Y-27632 is not suitable for in vivo applications without pharmacokinetic optimization due to rapid clearance and poor bioavailability in some animal models.
• Enhancement of stem cell viability is context-dependent and may not generalize across all cell types or culture conditions.

Workflow Integration & Parameters

Y-27632 dihydrochloride is typically supplied as a solid. It should be stored desiccated at 4°C or below. For solution preparation, dissolve in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), or water (≥52.9 mg/mL). Solubility is improved by warming to 37°C or brief sonication. Aliquots can be stored at -20°C for several months; avoid repeated freeze-thaw cycles. For in vitro use, typical working concentrations range from 1 μM to 10 μM, depending on cell type and assay. For stem cell passaging, 10 μM is commonly used [Watanabe 2007]. Always include control groups for baseline comparison. For additional technical details, consult the ApexBio product page and referenced protocols.

Conclusion & Outlook

Y-27632 dihydrochloride (A3008) is a critical reagent for probing Rho/ROCK signaling in cell biology, stem cell, and cancer research. Its robust selectivity and reproducibility support reliable mechanistic studies. As new applications emerge, particularly in regenerative medicine and cancer therapeutics, attention to workflow parameters and awareness of limitations will remain essential. For researchers seeking validated protocols and product information, refer to the ApexBio Y-27632 dihydrochloride page or recent comparative reviews.